HLA-DRB1 and type 2 diabetes mellitus: After Bonferroni correction, the DRB1*11 allelic group remained associated with protection against severe and critical cases, while DRB1*15 was linked to an increased risk of severity, independent of age, sex, smoking, cardiovascular diseases, and type 2 diabetes mellitus.